Bispecific and Trispecific Antibody Market, Global Outlook and Forecast 2022-2028

May 2022 | 106 pages | ID: BB123AFE28A7EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Bispecific and Trispecific Antibody in Global, including the following market information:

Global Bispecific and Trispecific Antibody Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Bispecific and Trispecific Antibody market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Bispecific Antibody Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bispecific and Trispecific Antibody include AbbVie, Affimed, Biotheus, Biontech, Genmab, GT Biopharma, Harpoon Therapeutics, MacroGenics and Numab, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bispecific and Trispecific Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bispecific and Trispecific Antibody Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Bispecific and Trispecific Antibody Market Segment Percentages, by Type, 2021 (%)

• Bispecific Antibody
• Trispecific Antibody

Global Bispecific and Trispecific Antibody Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Bispecific and Trispecific Antibody Market Segment Percentages, by Application, 2021 (%)

• Cancer
• Haemophilia
• Others

Global Bispecific and Trispecific Antibody Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Bispecific and Trispecific Antibody Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bispecific and Trispecific Antibody revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Bispecific and Trispecific Antibody revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie
• Affimed
• Biotheus
• Biontech
• Genmab
• GT Biopharma
• Harpoon Therapeutics
• MacroGenics
• Numab
• Sanofi
• Sichuan Baili Pharmaceuticals
• Roche
• Amgen
• Pfizer
• Johnson & Johnson
• AstraZeneca

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bispecific and Trispecific Antibody Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bispecific and Trispecific Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BISPECIFIC AND TRISPECIFIC ANTIBODY OVERALL MARKET SIZE

2.1 Global Bispecific and Trispecific Antibody Market Size: 2021 VS 2028
2.2 Global Bispecific and Trispecific Antibody Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Bispecific and Trispecific Antibody Players in Global Market
3.2 Top Global Bispecific and Trispecific Antibody Companies Ranked by Revenue
3.3 Global Bispecific and Trispecific Antibody Revenue by Companies
3.4 Top 3 and Top 5 Bispecific and Trispecific Antibody Companies in Global Market, by Revenue in 2021
3.5 Global Companies Bispecific and Trispecific Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bispecific and Trispecific Antibody Players in Global Market
  3.6.1 List of Global Tier 1 Bispecific and Trispecific Antibody Companies
  3.6.2 List of Global Tier 2 and Tier 3 Bispecific and Trispecific Antibody Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Bispecific and Trispecific Antibody Market Size Markets, 2021 & 2028
  4.1.2 Bispecific Antibody
  4.1.3 Trispecific Antibody
4.2 By Type - Global Bispecific and Trispecific Antibody Revenue & Forecasts
  4.2.1 By Type - Global Bispecific and Trispecific Antibody Revenue, 2017-2022
  4.2.2 By Type - Global Bispecific and Trispecific Antibody Revenue, 2023-2028
  4.2.3 By Type - Global Bispecific and Trispecific Antibody Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bispecific and Trispecific Antibody Market Size, 2021 & 2028
  5.1.2 Cancer
  5.1.3 Haemophilia
  5.1.4 Others
5.2 By Application - Global Bispecific and Trispecific Antibody Revenue & Forecasts
  5.2.1 By Application - Global Bispecific and Trispecific Antibody Revenue, 2017-2022
  5.2.2 By Application - Global Bispecific and Trispecific Antibody Revenue, 2023-2028
  5.2.3 By Application - Global Bispecific and Trispecific Antibody Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Bispecific and Trispecific Antibody Market Size, 2021 & 2028
6.2 By Region - Global Bispecific and Trispecific Antibody Revenue & Forecasts
  6.2.1 By Region - Global Bispecific and Trispecific Antibody Revenue, 2017-2022
  6.2.2 By Region - Global Bispecific and Trispecific Antibody Revenue, 2023-2028
  6.2.3 By Region - Global Bispecific and Trispecific Antibody Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Bispecific and Trispecific Antibody Revenue, 2017-2028
  6.3.2 US Bispecific and Trispecific Antibody Market Size, 2017-2028
  6.3.3 Canada Bispecific and Trispecific Antibody Market Size, 2017-2028
  6.3.4 Mexico Bispecific and Trispecific Antibody Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Bispecific and Trispecific Antibody Revenue, 2017-2028
  6.4.2 Germany Bispecific and Trispecific Antibody Market Size, 2017-2028
  6.4.3 France Bispecific and Trispecific Antibody Market Size, 2017-2028
  6.4.4 U.K. Bispecific and Trispecific Antibody Market Size, 2017-2028
  6.4.5 Italy Bispecific and Trispecific Antibody Market Size, 2017-2028
  6.4.6 Russia Bispecific and Trispecific Antibody Market Size, 2017-2028
  6.4.7 Nordic Countries Bispecific and Trispecific Antibody Market Size, 2017-2028
  6.4.8 Benelux Bispecific and Trispecific Antibody Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Bispecific and Trispecific Antibody Revenue, 2017-2028
  6.5.2 China Bispecific and Trispecific Antibody Market Size, 2017-2028
  6.5.3 Japan Bispecific and Trispecific Antibody Market Size, 2017-2028
  6.5.4 South Korea Bispecific and Trispecific Antibody Market Size, 2017-2028
  6.5.5 Southeast Asia Bispecific and Trispecific Antibody Market Size, 2017-2028
  6.5.6 India Bispecific and Trispecific Antibody Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Bispecific and Trispecific Antibody Revenue, 2017-2028
  6.6.2 Brazil Bispecific and Trispecific Antibody Market Size, 2017-2028
  6.6.3 Argentina Bispecific and Trispecific Antibody Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Bispecific and Trispecific Antibody Revenue, 2017-2028
  6.7.2 Turkey Bispecific and Trispecific Antibody Market Size, 2017-2028
  6.7.3 Israel Bispecific and Trispecific Antibody Market Size, 2017-2028
  6.7.4 Saudi Arabia Bispecific and Trispecific Antibody Market Size, 2017-2028
  6.7.5 UAE Bispecific and Trispecific Antibody Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AbbVie
  7.1.1 AbbVie Corporate Summary
  7.1.2 AbbVie Business Overview
  7.1.3 AbbVie Bispecific and Trispecific Antibody Major Product Offerings
  7.1.4 AbbVie Bispecific and Trispecific Antibody Revenue in Global Market (2017-2022)
  7.1.5 AbbVie Key News
7.2 Affimed
  7.2.1 Affimed Corporate Summary
  7.2.2 Affimed Business Overview
  7.2.3 Affimed Bispecific and Trispecific Antibody Major Product Offerings
  7.2.4 Affimed Bispecific and Trispecific Antibody Revenue in Global Market (2017-2022)
  7.2.5 Affimed Key News
7.3 Biotheus
  7.3.1 Biotheus Corporate Summary
  7.3.2 Biotheus Business Overview
  7.3.3 Biotheus Bispecific and Trispecific Antibody Major Product Offerings
  7.3.4 Biotheus Bispecific and Trispecific Antibody Revenue in Global Market (2017-2022)
  7.3.5 Biotheus Key News
7.4 Biontech
  7.4.1 Biontech Corporate Summary
  7.4.2 Biontech Business Overview
  7.4.3 Biontech Bispecific and Trispecific Antibody Major Product Offerings
  7.4.4 Biontech Bispecific and Trispecific Antibody Revenue in Global Market (2017-2022)
  7.4.5 Biontech Key News
7.5 Genmab
  7.5.1 Genmab Corporate Summary
  7.5.2 Genmab Business Overview
  7.5.3 Genmab Bispecific and Trispecific Antibody Major Product Offerings
  7.5.4 Genmab Bispecific and Trispecific Antibody Revenue in Global Market (2017-2022)
  7.5.5 Genmab Key News
7.6 GT Biopharma
  7.6.1 GT Biopharma Corporate Summary
  7.6.2 GT Biopharma Business Overview
  7.6.3 GT Biopharma Bispecific and Trispecific Antibody Major Product Offerings
  7.6.4 GT Biopharma Bispecific and Trispecific Antibody Revenue in Global Market (2017-2022)
  7.6.5 GT Biopharma Key News
7.7 Harpoon Therapeutics
  7.7.1 Harpoon Therapeutics Corporate Summary
  7.7.2 Harpoon Therapeutics Business Overview
  7.7.3 Harpoon Therapeutics Bispecific and Trispecific Antibody Major Product Offerings
  7.7.4 Harpoon Therapeutics Bispecific and Trispecific Antibody Revenue in Global Market (2017-2022)
  7.7.5 Harpoon Therapeutics Key News
7.8 MacroGenics
  7.8.1 MacroGenics Corporate Summary
  7.8.2 MacroGenics Business Overview
  7.8.3 MacroGenics Bispecific and Trispecific Antibody Major Product Offerings
  7.8.4 MacroGenics Bispecific and Trispecific Antibody Revenue in Global Market (2017-2022)
  7.8.5 MacroGenics Key News
7.9 Numab
  7.9.1 Numab Corporate Summary
  7.9.2 Numab Business Overview
  7.9.3 Numab Bispecific and Trispecific Antibody Major Product Offerings
  7.9.4 Numab Bispecific and Trispecific Antibody Revenue in Global Market (2017-2022)
  7.9.5 Numab Key News
7.10 Sanofi
  7.10.1 Sanofi Corporate Summary
  7.10.2 Sanofi Business Overview
  7.10.3 Sanofi Bispecific and Trispecific Antibody Major Product Offerings
  7.10.4 Sanofi Bispecific and Trispecific Antibody Revenue in Global Market (2017-2022)
  7.10.5 Sanofi Key News
7.11 Sichuan Baili Pharmaceuticals
  7.11.1 Sichuan Baili Pharmaceuticals Corporate Summary
  7.11.2 Sichuan Baili Pharmaceuticals Business Overview
  7.11.3 Sichuan Baili Pharmaceuticals Bispecific and Trispecific Antibody Major Product Offerings
  7.11.4 Sichuan Baili Pharmaceuticals Bispecific and Trispecific Antibody Revenue in Global Market (2017-2022)
  7.11.5 Sichuan Baili Pharmaceuticals Key News
7.12 Roche
  7.12.1 Roche Corporate Summary
  7.12.2 Roche Business Overview
  7.12.3 Roche Bispecific and Trispecific Antibody Major Product Offerings
  7.12.4 Roche Bispecific and Trispecific Antibody Revenue in Global Market (2017-2022)
  7.12.5 Roche Key News
7.13 Amgen
  7.13.1 Amgen Corporate Summary
  7.13.2 Amgen Business Overview
  7.13.3 Amgen Bispecific and Trispecific Antibody Major Product Offerings
  7.13.4 Amgen Bispecific and Trispecific Antibody Revenue in Global Market (2017-2022)
  7.13.5 Amgen Key News
7.14 Pfizer
  7.14.1 Pfizer Corporate Summary
  7.14.2 Pfizer Business Overview
  7.14.3 Pfizer Bispecific and Trispecific Antibody Major Product Offerings
  7.14.4 Pfizer Bispecific and Trispecific Antibody Revenue in Global Market (2017-2022)
  7.14.5 Pfizer Key News
7.15 Johnson & Johnson
  7.15.1 Johnson & Johnson Corporate Summary
  7.15.2 Johnson & Johnson Business Overview
  7.15.3 Johnson & Johnson Bispecific and Trispecific Antibody Major Product Offerings
  7.15.4 Johnson & Johnson Bispecific and Trispecific Antibody Revenue in Global Market (2017-2022)
  7.15.5 Johnson & Johnson Key News
7.16 AstraZeneca
  7.16.1 AstraZeneca Corporate Summary
  7.16.2 AstraZeneca Business Overview
  7.16.3 AstraZeneca Bispecific and Trispecific Antibody Major Product Offerings
  7.16.4 AstraZeneca Bispecific and Trispecific Antibody Revenue in Global Market (2017-2022)
  7.16.5 AstraZeneca Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Bispecific and Trispecific Antibody Market Opportunities & Trends in Global Market
Table 2. Bispecific and Trispecific Antibody Market Drivers in Global Market
Table 3. Bispecific and Trispecific Antibody Market Restraints in Global Market
Table 4. Key Players of Bispecific and Trispecific Antibody in Global Market
Table 5. Top Bispecific and Trispecific Antibody Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Bispecific and Trispecific Antibody Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Bispecific and Trispecific Antibody Revenue Share by Companies, 2017-2022
Table 8. Global Companies Bispecific and Trispecific Antibody Product Type
Table 9. List of Global Tier 1 Bispecific and Trispecific Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bispecific and Trispecific Antibody Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Bispecific and Trispecific Antibody Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Bispecific and Trispecific Antibody Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Bispecific and Trispecific Antibody Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Bispecific and Trispecific Antibody Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Bispecific and Trispecific Antibody Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Bispecific and Trispecific Antibody Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Bispecific and Trispecific Antibody Product Offerings
Table 32. AbbVie Bispecific and Trispecific Antibody Revenue (US$, Mn), (2017-2022)
Table 33. Affimed Corporate Summary
Table 34. Affimed Bispecific and Trispecific Antibody Product Offerings
Table 35. Affimed Bispecific and Trispecific Antibody Revenue (US$, Mn), (2017-2022)
Table 36. Biotheus Corporate Summary
Table 37. Biotheus Bispecific and Trispecific Antibody Product Offerings
Table 38. Biotheus Bispecific and Trispecific Antibody Revenue (US$, Mn), (2017-2022)
Table 39. Biontech Corporate Summary
Table 40. Biontech Bispecific and Trispecific Antibody Product Offerings
Table 41. Biontech Bispecific and Trispecific Antibody Revenue (US$, Mn), (2017-2022)
Table 42. Genmab Corporate Summary
Table 43. Genmab Bispecific and Trispecific Antibody Product Offerings
Table 44. Genmab Bispecific and Trispecific Antibody Revenue (US$, Mn), (2017-2022)
Table 45. GT Biopharma Corporate Summary
Table 46. GT Biopharma Bispecific and Trispecific Antibody Product Offerings
Table 47. GT Biopharma Bispecific and Trispecific Antibody Revenue (US$, Mn), (2017-2022)
Table 48. Harpoon Therapeutics Corporate Summary
Table 49. Harpoon Therapeutics Bispecific and Trispecific Antibody Product Offerings
Table 50. Harpoon Therapeutics Bispecific and Trispecific Antibody Revenue (US$, Mn), (2017-2022)
Table 51. MacroGenics Corporate Summary
Table 52. MacroGenics Bispecific and Trispecific Antibody Product Offerings
Table 53. MacroGenics Bispecific and Trispecific Antibody Revenue (US$, Mn), (2017-2022)
Table 54. Numab Corporate Summary
Table 55. Numab Bispecific and Trispecific Antibody Product Offerings
Table 56. Numab Bispecific and Trispecific Antibody Revenue (US$, Mn), (2017-2022)
Table 57. Sanofi Corporate Summary
Table 58. Sanofi Bispecific and Trispecific Antibody Product Offerings
Table 59. Sanofi Bispecific and Trispecific Antibody Revenue (US$, Mn), (2017-2022)
Table 60. Sichuan Baili Pharmaceuticals Corporate Summary
Table 61. Sichuan Baili Pharmaceuticals Bispecific and Trispecific Antibody Product Offerings
Table 62. Sichuan Baili Pharmaceuticals Bispecific and Trispecific Antibody Revenue (US$, Mn), (2017-2022)
Table 63. Roche Corporate Summary
Table 64. Roche Bispecific and Trispecific Antibody Product Offerings
Table 65. Roche Bispecific and Trispecific Antibody Revenue (US$, Mn), (2017-2022)
Table 66. Amgen Corporate Summary
Table 67. Amgen Bispecific and Trispecific Antibody Product Offerings
Table 68. Amgen Bispecific and Trispecific Antibody Revenue (US$, Mn), (2017-2022)
Table 69. Pfizer Corporate Summary
Table 70. Pfizer Bispecific and Trispecific Antibody Product Offerings
Table 71. Pfizer Bispecific and Trispecific Antibody Revenue (US$, Mn), (2017-2022)
Table 72. Johnson & Johnson Corporate Summary
Table 73. Johnson & Johnson Bispecific and Trispecific Antibody Product Offerings
Table 74. Johnson & Johnson Bispecific and Trispecific Antibody Revenue (US$, Mn), (2017-2022)
Table 75. AstraZeneca Corporate Summary
Table 76. AstraZeneca Bispecific and Trispecific Antibody Product Offerings
Table 77. AstraZeneca Bispecific and Trispecific Antibody Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Bispecific and Trispecific Antibody Segment by Type in 2021
Figure 2. Bispecific and Trispecific Antibody Segment by Application in 2021
Figure 3. Global Bispecific and Trispecific Antibody Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bispecific and Trispecific Antibody Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bispecific and Trispecific Antibody Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bispecific and Trispecific Antibody Revenue in 2021
Figure 8. By Type - Global Bispecific and Trispecific Antibody Revenue Market Share, 2017-2028
Figure 9. By Application - Global Bispecific and Trispecific Antibody Revenue Market Share, 2017-2028
Figure 10. By Region - Global Bispecific and Trispecific Antibody Revenue Market Share, 2017-2028
Figure 11. By Country - North America Bispecific and Trispecific Antibody Revenue Market Share, 2017-2028
Figure 12. US Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Bispecific and Trispecific Antibody Revenue Market Share, 2017-2028
Figure 16. Germany Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 17. France Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Bispecific and Trispecific Antibody Revenue Market Share, 2017-2028
Figure 24. China Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 28. India Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Bispecific and Trispecific Antibody Revenue Market Share, 2017-2028
Figure 30. Brazil Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Bispecific and Trispecific Antibody Revenue Market Share, 2017-2028
Figure 33. Turkey Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Bispecific and Trispecific Antibody Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Bispecific and Trispecific Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Affimed Bispecific and Trispecific Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Biotheus Bispecific and Trispecific Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Biontech Bispecific and Trispecific Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Genmab Bispecific and Trispecific Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GT Biopharma Bispecific and Trispecific Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Harpoon Therapeutics Bispecific and Trispecific Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. MacroGenics Bispecific and Trispecific Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Numab Bispecific and Trispecific Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sanofi Bispecific and Trispecific Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sichuan Baili Pharmaceuticals Bispecific and Trispecific Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Roche Bispecific and Trispecific Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Amgen Bispecific and Trispecific Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Pfizer Bispecific and Trispecific Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Johnson & Johnson Bispecific and Trispecific Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. AstraZeneca Bispecific and Trispecific Antibody Revenue Year Over Year Growth (US$, Mn) & (2017-2022)